4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-061426
Chief Executive Officer sold 65,000 shares at an average $65.77 ($4,274,982)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-20 | Sale : show line 1 in the form | −15,000 | $66.23 | $993,450 | 3,329,022 | D |
| 2021-10-22 | Sale : show line 2 in the form | −44,170 | $65.57 | $2,896,227 | 3,284,852 | D |
| 2021-10-22 | Sale : show line 3 in the form | −5,830 | $66.09 | $385,305 | 3,279,022 | D |
| Open-market sales · 65,000 sh · avg $65.77 · $4,274,982 | ||||||
Loading xslF345X03/doc4.xml…